Sequential Amiodarone-Induced Thyroid Dysfunction: From Myxedema Coma to Late-Onset Type 1 Thyrotoxicosis After Drug Withdrawal. [PDF]
ABSTRACT Amiodarone therapy may induce thyroid dysfunction in approximately 20% of patients, either amiodarone‐induced hypothyroidism (AIH) or thyrotoxicosis (AIT). Both situations may occur at any time during treatment or even months to years after drug withdrawal due to tissue storage with slow systemic release.
Soares DM, Ferreira L.
europepmc +2 more sources
An Atypical Case of Myxedema Coma with Concomitant Nonconvulsive Seizure [PDF]
Hypothyroidism is a prevalent condition in the general population that is treatable with appropriately dosed thyroid hormone replacement medication.
Pratik Patel +3 more
doaj +2 more sources
Myxedema Coma Associated with Macroprolactinoma: Case Report and Review of the Literature
Myxedema coma is a rare life-threatening presentation of severe hypothyroidism associated with a high mortality rate. Although most cases are due to primary thyroid failure, a minority have central hypothyroidism as the underlying cause.
Elizabeth Jasola Omoniyi +1 more
doaj +2 more sources
Look into hypothermia and hyponatremia in a myxedema coma case
Background/objective: Given high mortality rates, understanding the management of associated hypothermia and hyponatremia in the myxedema coma remains crucial.
Amrit Pathak +2 more
doaj +2 more sources
Botulinum toxin injection induced autoimmune thyroiditis and myxedema coma: A case report [PDF]
This case describes a 28-year-old female with amyotrophic lateral sclerosis and recurrent urinary tract infections who developed myxedema coma following a botulinum toxin type-A (Btx) injection for muscle spasticity. On intensive care unit admission, she
Khaled Gazwi +4 more
doaj +2 more sources
Clinical course of myxedema coma in an Alzheimer’s disease patient and co-founding of J wave: A case report [PDF]
Myxedema coma is a rare condition and is associated with a high mortality rate. Management has been based on the medical experience due to its rarity.
Manar Shalak +3 more
doaj +2 more sources
Myxedema coma is a rare life-threatening form of hypothyroidism that manifests as neuropsychiatric, metabolic, respiratory, and cardiovascular dysfunction. From 2010 to 2022, our hospital managed three cases of myxedema coma.
Yosuke Okuno +5 more
doaj +2 more sources
Legions of Presentations of Myxedema Coma [PDF]
Myxedema coma is associated with decreased mental status and hyponatremia among patients with diagnosed or undiagnosed hypothyroidism. The diagnosis is challenging in the absence of universally accepted diagnostic criteria, but should be considered as a
Nirmalya Roy +5 more
doaj +2 more sources
An autopsy case report of a patient with myxedema coma
Background Myxedema coma, a life-threatening complication of severe hypothyroidism, is associated with high mortality. Detailed autopsy findings from multiple organs in myxedema coma are rarely reported.
Syuichi Tetsuka
exaly +2 more sources
Mechanical Circulatory Support in Management of Cardiogenic Shock and Myxedema Coma [PDF]
The cardiovascular system is a major target of thyroid hormone action and the two systems are closely interlinked. It can be greatly impacted even with subtle alterations in thyroid function.
Jelena Z. Arnautovic +2 more
doaj +3 more sources

